You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美讨论区狙击生物医药股BioCryst淡仓 该股暴涨逾四成
阿思达克 02-02 10:03
美国Reddit讨论区「对赌华尔街」(WallStreetBets)群组股票狙击行动持续。生物医药股股BioCryst(BCRX.US)股价昨日(1日)在美股暴涨39.1%报11.85美元,其後在延长交易时段再升8.7%报12.88美元。

该股最新完成研发新冠治疗药,Reddit讨论区帖文指该股为股市中最被低估的股份,其他网民起哄发起「生化战」(#BioWar)并挟淡仓。

据金融分析公司S3 Partners,BioCryst淡仓总值占流通股17%,相等2.59亿美元。但对冲基金Citadel、Baker兄弟及维权投资者Alex Denner旗下Sarissa资本管理等对冲基金则看好该股。其中Citadel早前参与因网民挟淡仓导致严重损手的Melvin Capital的注资。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account